JMPWA
BHVN

JP Morgan Private Wealth Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,181
Closed -$330K – 2036
2022
Q3 		$330K Sell
2,181
-5,935
-73% -$880K ﹤0.01% 1616
2022
Q2 		$1.18M Sell
8,116
-11,169
-58% -$1.43M ﹤0.01% 1048
2022
Q1 		$2.29M Sell
19,285
-7,972
-29% -$994K 0.01% 857
2021
Q4 		$3.76M Buy
27,257
+6,376
+31% +$811K 0.01% 694
2021
Q3 		$2.9M Buy
20,881
+7,318
+54% +$914K 0.01% 755
2021
Q2 		$1.32M Buy
13,563
+8,870
+189% +$720K ﹤0.01% 1061
2021
Q1 		$321K Buy
+4,693
New +$380K ﹤0.01% 1501

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

JP Morgan Private Wealth Advisors's BHVN Position: Q4 2022 in Review

JP Morgan Private Wealth Advisors sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 2,181 shares — an estimated $330K sold.

JP Morgan Private Wealth Advisors first reported a position in BHVN in Q1 2021 and held it in 7 quarters. The position peaked at $3.76M in Q4 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 2,181 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $330K.
  • JP Morgan Private Wealth Advisors first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2021 and held it in 7 quarters.
  • JP Morgan Private Wealth Advisors's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $3.76M in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.